<img height="1" width="1" src="https://www.facebook.com/tr?id=1582471781774081&amp;ev=PageView &amp;noscript=1">
x

In Vivo Syngeneic Screening Platform for Immunotherapeutics

Syngeneic tumor models are the current workhorse in immunotherapy evaluation. They have a long history in oncology drug development, and represent valuable tools in both targeted and immuno-oncology agent assessment.